Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation

International Journal of Biological Macromolecules

Volumn 61, Issue , 2013, Pages 26-32

  Shahzad, Yasser ^a   Khan, Qalandar ^b   Hussain, Talib ^a   Shah, Syed Nisar Hussain ^b  

^a UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^b BAHAUDDIN ZAKARIYA UNIVERSITY   (Pakistan)

Author keywords

Design of experiment; Flux; Lornoxicam; Lotion; Permeation

Indexed keywords

CELLULOSE DERIVATIVE; ETHYLENE GLYCOL; HYDROXYPROPYLMETHYLCELLULOSE; LORNOXICAM; POLYMER; SILICONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; DRUG STABILITY; DRUG TRANSPORT; IN VITRO STUDY; MEMBRANE PERMEABILITY; NONHUMAN; PH; PROCESS OPTIMIZATION; RABBIT; SKIN PERMEABILITY; TRANSDERMAL DRUG ADMINISTRATION; VISCOSITY;

EID: 84880603553     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2013.06.049     Document Type: Article

References (37)

1. Wang S., Chow M.S.S., Zuo Z. International Journal of Pharmaceutics 2011, 420:43-50.
2. Hamza Y.E.S., Aburahma M.H. Drug Development and Industrial Pharmacy 2010, 36:337-349.
3. Kidd B., Frenzel W. Journal of Rheumatology 1996, 23:1605-1611.
4. Homdrum E.M., Likar R., Nell G. European Surgery - Acta Chirurgica Austriaca 2006, 38:342-352.
5. Hamza Y.E.S., Aburahma M.H. AAPS PharmSciTech 2009, 10:1357-1367.
6. Skjodt N.M., Davies N.M. Clinical Pharmacokinetics 1998, 34:421-428.
7. Aburahma M.H., Hamza Y.E.S. Pharmaceutical Development and Technology 2011, 16:316-330.
8. Ammar H., Ghorab M., Mahmoud A., Makram T., Noshi S. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2012, 73:161-175.
9. Shahzad Y., Shah S.N.H., Ansari M.T., Riaz R., Safdar A., Hussain T., Malik M. Chinese Science Bulletin 2012, 57:1685-1692.
10. Pathan I.B., Setty C.M. Tropical Journal of Pharmaceutical Research 2009, 8:173-179.
11. Shah S.N.H., Rabbani M.E., Shahzad Y., Badshah A., Meidan V.M., Murtaza G. Journal of Food and Drug Analysis 2012, 20:464-470.
12. Chaudhary H., Rohilla A., Rathee P., Kumar V. International Journal Biological Macromolecule 2013, 55:246-253.
13. Sacchetti M. Journal of Pharmaceutical Sciences 2001, 90:1004-1014.
14. Wu P.-C., Obata Y., Fujikawa M., Li C.J., Higashiyama K., Takayama K. Journal of Pharmaceutical Sciences 2001, 90:1004-1014.
15. Huang Y.-B., Wang R.-J., Chang J.-S., Tsai Y.-H., Wu P.-C. International Journal of Pharmaceutics 2007, 339:47-51.
16. Chang J.S., Huang Y.B., Hou S.S., Wang R.J., Wu P.C., Tsai Y.H. International Journal of Pharmaceutics 2007, 338:48-54.
17. Obata Y., Ashitaka Y., Kikuchi S., Isowa K., Takayama K. International Journal of Pharmaceutics 2010, 399:87-93.
18. Ghica M.V., Albu M.G., Leca M., Popa L., Moisescu S.T. Pharmazie 2011, 66:853-861.
19. Shahzad Y., Afreen U., Shah S.N.H., Hussain T. Pharmaceutical Development and Technology 2012, 1-8. 10.3109/10837450.2012.723721.
20. Shah S.N.H., Asghar S., Choudhry M.A., Akash M.S.H., Rehman N.U., Baksh S. Drug Development and Industrial Pharmacy 2009, 35:1470-1478.
21. Quiñones D., Ghaly E.S. Peurto Rico Health Sciences Journal 2008, 27:61-67.
22. Alonzo D.E., Raina S., Zhou D., Gao Y., Zhang G.G.Z., Taylor L.S. Crystal Growth and Design 2012, 12:1538-1547.
23. Iervolino M., Cappello B., Raghavan S.L., Hadgraft J. International Journal of Pharmaceutics 2001, 212:131-141.
24. Sun J.D., Frantz S.W., Beskitt J.L. Journal of Toxicology-Cutaneous and Ocular Toxicology 1995, 14:273-286.
25. Saghir S.A., Bartels M.J., Snellings W.M. International Journal of Toxicology 2010, 29:268-276.
26. Zhang J., Li L., Gao Y., Fan W. Pakistan Journal of Pharmaceutical Sciences 2012, 25:371-375.
27. Meidan V.M., Pritchard D. European Journal of Pharmaceutics and Biopharmaceutics 2010, 74:513-517.
28. Chang J.S., Wu P.C., Huang Y.B., Tsai Y.H. Journal of Food Drug Analysis 2006, 14:236-241.
29. Hamza Y.E.S., Aburahma M.H. Pharmaceutical Development and Technology 2010, 15:139-153.
30. Haigh J.M., Smith E.W. European Journal of Pharmaceutical Sciences 1994, 2:311-330.
31. Ottaviani G., Martel S., Carrupt P.A. Journal of Medicinal Chemistry 2006, 49:3948-3954.
32. Ng S.F., Rouse J.J., Sanderson F.D., Meidan V., Eccleston G.M. AAPS PharmSciTech 2010, 11:1432-1441.
33. Cho C.W., Choi J.S., Shin S.C. Drug Development and Industrial Pharmacy 2008, 34:330-335.
34. El Maghraby G.M., Alanazi F.K., Alsarra I.A. Drug Development and Industrial Pharmacy 2009, 35:329-336.
35. Iervolino M., Raghavan S.L., Hadgraft J. International Journal of Pharmaceutics 2000, 198:229-238.
36. Farrell M., Beaudoin S. Colloids and Surfaces B: Biointerfaces 2010, 81:468-475.
37. Batheja P., Sheihet L., Kohn J., Singer A.J., Michniak-Kohn B. Journal of Controlled Release 2011, 149:159-167.